Cefobot 1000 Injection contains Cefotaxime 1000 mg, a broad-spectrum third-generation cephalosporin antibiotic. It works by inhibiting bacterial cell wall synthesis, effectively killing a wide range of Gram-positive and Gram-negative bacteria. The formulation is administered through intramuscular or intravenous injection, ensuring rapid therapeutic action against severe infections such as pneumonia, meningitis, urinary tract infections, and intra-abdominal or bone infections.
It helps in the anti-infective segment, offering a reliable solution for hospitals and healthcare professionals managing serious bacterial infections. Cefotaxime is often used when oral antibiotics are ineffective or when immediate therapeutic response is needed. Its strong bactericidal activity and established clinical safety make Cefobot 100 a preferred choice among physicians.
From a B2B and PCD franchise perspective, Cefobot 100 Injection is a high-demand hospital-use product. Injectable antibiotics are key items in every hospital’s essential medicine list, ensuring steady prescription flow and business growth. The product’s compliance with WHO-GMP manufacturing standards and its proven efficacy make it ideal for distributors, franchise holders, and institutional suppliers.
Partnering for Cefobot 100 Injection gives you access to a premium quality antibiotic with consistent demand across healthcare setups. Its reliable results, trusted formulation, and competitive pricing structure make it an essential addition to any anti-infective or general medicine product portfolio—ensuring both patient care excellence and profitable business outcomes.